H.I.G. Capital Completes Recapitalization of Navitas Life Sciences
H.I.G. Capital, a global alternative investment firm with more than $50 billion of equity capital under management, is pleased to announce that one of its affiliates has completed the recapitalization of Navitas Life Sciences.
September 14, 2022
Camilo E. Horvilleur | H.I.G. Capital | Navitas Life Sciences | Srinivasan HR
Ian Koplin